Table 2.
Variable | Bangladesh n = 67 (%) |
India n = 61 (%) |
Malaysia n = 41 (%) |
Turkey n = 54 (%) |
Overall n = 223 (%) |
---|---|---|---|---|---|
Signs and symptoms | 27 (40.30) | 25 (40.98) | 18 (43.9) | 27 (50) | 97 (43.50) |
Diagnostic tests | 15 (22.39) | 20 (32.79) | 6 (14.63) | 7 (12.96) | 48 (21.52) |
Parameters in complete blood count | 6 (8.96) | 14 (22.95) | 26 (63.41) | 6 (11.11) | 52 (23.32) |
Platelet count for hospital admission | 19 (28.36) | 20 (32.79) | 11 (26.83) | 13 (24.07) | 63 (28.25) |
Plasma leakage | 10 (14.93) | 11 (18.03) | 3 (7.32) | 3 (5.56) | 27 (12.11) |
Treatment option | 67 (100) | 60 (98.36) | 40 (97.56) | 34 (62.96) | 201 (90.13) |
Paracetamol dosage frequency | 16 (23.88) | 29 (47.54) | 21 (51.22) | 9 (16.67) | 75 (33.63) |
Paracetamol maximum dosage | 22 (32.84) | 28 (45.90) | 24 (58.54) | 25 (46.30) | 99 (44.39) |
Paracetamol adverse effects | 6 (8.96) | 11 (18.03) | 1 (2.44) | 9 (16.67) | 27 (12.11) |
NSAIDs, corticosteroids contraindication | 66 (98.51) | 55 (90.16) | 40 (97.56) | 26 (48.15) | 187 (83.86) |
Reason for NSAIDs/steroids contraindication | 8 (12.12) | 12 (20.34) | 3 (7.32) | 2 (4.44) | 25 (11.21) |
Initiation of IV fluid therapy | 2 (2.99) | 2 (3.28) | 8 (19.51) | 1 (1.85) | 13 (5.83) |
Role of IV fluid therapy | 59 (88.06) | 50 (81.97) | 31 (75.61) | 23 (42.59) | 163 (73.09) |
IV fluid in restoring blood pressure | 33 (49.25) | 33 (54.10) | 21 (51.22) | 20 (37.04) | 107 (47.98) |
Initiation of blood transfusion | 10 (14.93) | 9 (14.75) | 4 (9.76) | 8 (14.81) | 31 (13.90) |
Discharge criteria | 34 (50.75) | 34 (55.74) | 10 (24.39) | 37 (68.52) | 115 (51.57) |
Complications of dengue fever | 54 (80.6) | 53 (86.89) | 34 (82.93) | 26 (48.15) | 167 (74.89) |
Early signs of dengue hemorrhagic fever | 21 (32.31) | 27 (44.26) | 17 (42.50) | 15 (28.30) | 80 (35.87) |
Early signs of dengue shock syndrome | 16 (25.00) | 19 (31.15) | 19 (46.34) | 8 (14.81) | 62 (27.80) |